Skip to content

Author

Muslim Alkafaji

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

The Impact of Infliximab Trough Level and Anti-Drug Antibody on Clinical Outcomes in Crohn's Disease Patients: A Cross-Sectional Study in Iraq

Introduction: Primary non-response and secondary loss of response, often mediated by the development of anti-drug antibodies (ADAs), limit treatment efficacy. Therapeutic drug monitoring (TDM) is gaining importance in optimizing infliximab therapy by correlating drug levels with clinical outcomes. This study aimed to i...

Ahmad K. Al-Jalehawi, Mahmoud A. Alkindy, Muslim Alkafaji et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.